Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Regorafenib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Stivarga

    02 1StivargaTM

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 575

    2019 Revenue in Millions : 497

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 525

    2020 Revenue in Millions : 575

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 644

    2021 Revenue in Millions : 525

    Growth (%) : 23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 567

    2022 Revenue in Millions : 644

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 488

    2023 Revenue in Millions : 567

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2015 Revenue in Millions : 246

    2014 Revenue in Millions : 344

    Growth (%) : 40%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : StivargaTM

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : StivargaTM

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2014 Revenue in Millions : 13.70%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2017 Revenue in Millions : 391

    2016 Revenue in Millions : 341

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 356

    2017 Revenue in Millions : 356

    Growth (%) : 0%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Stivarga

    Regorafenib

    arrow
    Pharma
    Not Confirmed

    Brand Name : Stivarga

    Germany
    arrow
    Pharma
    Not Confirmed

    Bayer

    Regorafenib

    Main Therapeutic Indication : Oncology

    Currency : USD

    2016 Revenue in Millions : 292

    2015 Revenue in Millions : 332

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.